Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - NovaBay Pharmaceuticals, Inc. | nby20150320_10k.htm |
| EX-31.2 - EXHIBIT 31.2 - NovaBay Pharmaceuticals, Inc. | ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - NovaBay Pharmaceuticals, Inc. | ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - NovaBay Pharmaceuticals, Inc. | ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - NovaBay Pharmaceuticals, Inc. | ex31-1.htm |
| EX-10.28 - EXHIBIT 10.28 - NovaBay Pharmaceuticals, Inc. | ex10-28.htm |
| EX-10.29 - EXHIBIT 10.29 - NovaBay Pharmaceuticals, Inc. | ex10-29.htm |
| EXCEL - IDEA: XBRL DOCUMENT - NovaBay Pharmaceuticals, Inc. | Financial_Report.xls |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-196764, 333-194383, 333-185998, 333-180461, 333-171981, 333-147334, 333-157041, and 333-164469) and Form S-3 (File Nos. 333-159917 and 333-180460) of NovaBay Pharmaceuticals, Inc. of our report dated March 25, 2015, relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.
San Francisco, California
March 25, 2015